BioAsia Investment in Telangana
Sector: Life Sciences • Location: Hyderabad, Telangana, India
Source: Siasat.com
Telangana received investments worth Rs 15,000 crore during the BioAsia summit 2025, highlighting its role as a major hub for life sciences and IT exports. The state is focusing on establishing a vaccine testing facility at Genome Valley to enhance its biotech innovation capabilities.
- Status
- Closed
- Sector
- Life Sciences
- Location
- Hyderabad, Telangana, India
- Updated
- 22 Jul 2026
- Source
- Siasat.com
ConstructChat
Ask ConstructChat about BioAsia Investment in Telangana
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Awarded |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Telangana received investments worth Rs 15,000 crore during the BioAsia summit 2025, highlighting its role as a major hub for life sciences and IT exports. The state is focusing on establishing a vaccine testing facility at Genome Valley to enhance its biotech innovation capabilities. |
Original sector | Life Sciences |
Budget |
Location
Country | India |
State | Telangana |
City | Hyderabad |
Source
Source | Siasat.com |
URL |
More Details
Record type | Project |
Article published date | 2025-03-03 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project